Tumor suppressor miR-30c is known to inhibit prostate cancer by targeting the 3′-UTR of the SRSF1 splicing factor oncoprotein to downregulate its expression in prostate cancer (41). This evidence concerns the gene SRSF1 and prostate cancer.